$BSVN

Estes Jason E sold $248K of BSVN

Estes Jason E (Exec. Vice President; CCO) sold 5,049 shares of Bank7 Corp. (BSVN) at an average of $49.05 ($48.25–$49.70, $0.25M total) across 3 trades over 2026-07-21 to 2026-07-22.

Original reporting
SEC EDGAR · Estes Jason E
Published Jul 23, 2026, 1:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 1:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BSVN
Neutral
medium confidence
Mentioned
$BSVN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BSVNNeutralLow
01

Why it matters

The newest disclosed fact is the insider’s open-market sale details and post-transaction holdings; it may slightly affect sentiment but provides no new operating or financial information.

02

Market read

Traders may monitor insider activity as a sentiment input, but this specific filing lacks a fundamental catalyst.

03

What to watch

The filing does not disclose reasons for the sale, whether proceeds were used for taxes, or whether other insiders made offsetting purchases.

Relevance 4/10Novelty 5/10Timing: filed 2026-07-23, covering sales executed 2026-07-21 to 2026-07-22

Background

The article is an SEC EDGAR Form 4 insider transaction for Bank7 Corp. (BSVN).

Company-level read

Ticker impact

$BSVNNeutralMedium confidence
Context

SEC Form 4 shows Estes Jason E, BSVN Exec VP and CCO, sold $247,668 of shares in open-market trades on 2026-07-21 to 2026-07-22.

Expected impact

Likely limited near-term impact; any effect is more about sentiment than new fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction, not an earnings, guidance, or operational update. The disclosed sale size is moderate and lacks accompanying company-specific news.

Market effects

No sector read-across; this is company-specific insider dealing.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for diversification or tax needs; the absence of a stated 10b5-1 plan does not automatically imply negative expectations.

Key entities

  • Bank7 Corp.

    Subject of the Form 4 insider transaction disclosure.

  • Estes Jason E

    Exec VP and CCO who sold 5,049 shares across three trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BSVNMed

Piper Sandler raises Bank7 stock price target on strong growth

Piper Sandler raised its price target for Bank7 Corp. (BSVN) to $69.00, citing strong Q3 results with 2.24% return on assets and 16.4% return on tangible common equity. The stock is near its 52-week high, up 38% year-to-date. Piper Sandler also increased its EPS estimates for 2026 and 2027, anticipating growth from the Century Bank acquisition. Bank7 reported Q3 earnings of $1.06 per share, beating estimates, but missed on revenue.

$BSVNMed

Bank7 (BSVN) Q3 2026 Earnings Call Transcript

Bank7 (BSVN) reported Q3 2026 earnings, highlighting strong deposit growth and an upcoming merger with Century in New Mexico. The merger is expected to be neutral to their net interest margin (NIM) but will provide cheaper funding. Bank7 plans to maintain its loan growth trajectory and deploy excess liquidity methodically. Century's loan portfolio will be integrated similarly to Bank7's existing strategy.

$BSVNHighAI 8/10

Bank7 Q3 2026 slides: earnings beat forecast as Century merger nears

Bank7 Corp (BSVN) reported Q3 2026 earnings of $1.06 per share, beating estimates, with revenue at $23.37M, slightly below forecasts. Stock rose 2.02% in premarket trading. The bank saw 22.3% net income growth and announced a $137M acquisition of Century Financial, expected to close November 1, 2026, adding $1.2B in deposits. Management expects EPS accretion of over 25% from the deal.

$BSVNMed

Bank7: Q3 Earnings Presentation

Bank7 reported Q3 2026 earnings with total assets of $2.01B, net income of $10.2M, and diluted EPS of $1.06. Key metrics include a 22.3% increase in net income and a 21.8% rise in EPS. The bank announced an acquisition of Century Financial for $137M, expected to close November 1, 2026, with projected EPS accretion of 25%.